$QUBT
Quantum Computing Inc. Stock $qubt

$qubt Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023038633 Filed on May 12, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$112.2K	$120.5K	$31.24K
YoY Change	71.32%	285.82%
Cost Of Revenue	$51.16K	$56.24K	$11.57K
YoY Change	877.58%	386.08%
Gross Profit	$61.03K	$64.29K	$19.67K
YoY Change	1.3%	226.85%
Gross Profit Margin	54.4%	53.34%	62.96%
Selling, General & Admin	-$325.4K	$2.670M	$5.704M
YoY Change	-115.64%	-53.2%	106.09%
% of Gross Profit	-533.1%	4152.55%	28998.58%
Research & Development	$1.585M	$1.535M	$1.025M
YoY Change	86.34%	49.78%	63.82%
% of Gross Profit	2596.48%	2386.95%	5208.9%
Depreciation & Amortization	$60.32K	$1.544M	$3.040K
YoY Change	-76.27%	50693.75%	50.5%
% of Gross Profit	98.83%	2401.78%	15.46%
Operating Expenses	$3.920M	$7.852M	$6.729M
YoY Change	-19.48%	16.69%	98.3%
Operating Profit	-$3.859M	-$7.788M	-$6.709M
YoY Change	-19.74%	16.08%	97.72%
Interest Expense	-$568.2K	-$502.9K	-$201.6K
YoY Change	677.44%	149.41%	-14711.59%
% of Operating Profit
Other Income/Expense, Net	-$783.4K	-$718.6K	-$223.1K
YoY Change	164.46%	222.07%
Pretax Income	-$4.642M	-$8.506M	-$7.134M
YoY Change	-9.05%	19.24%	110.32%
Income Tax
% Of Pretax Income
Net Earnings	-$4.642M	-$8.506M	-$7.134M
YoY Change	-9.05%	19.24%	110.33%
Net Earnings / Revenue	-4138.02%	-7057.28%	-22835.12%
Basic Earnings Per Share	-$0.07	-$0.14	-$0.24
Diluted Earnings Per Share	-$0.05	-$0.11	-$244.7K
COMMON SHARES
Basic Shares Outstanding	61.51M shares	60.50M shares	29.16M shares
Diluted Shares Outstanding	88.94M shares	78.82M shares	38.14M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.197M	$6.765M	$11.51M
YoY Change	6.73%	-41.24%	-16.36%
Cash & Equivalents	$7.197M	$6.765M	$11.51M
Short-Term Investments
Other Short-Term Assets	$11.57K	$42.39K	$464.4K
YoY Change	-97.88%	-90.87%	59.25%
Inventory
Prepaid Expenses	$202.2K	$224.3K
Receivables	$121.4K	$63.01K	$1.284M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.037M	$7.095M	$13.26M
YoY Change	9.02%	-46.5%	-5.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.451M	$1.309M	$41.69K
YoY Change	804.9%	3040.08%	26.41%
Goodwill	$65.11M	$59.13M
YoY Change	10.12%
Intangibles	$12.81M	$20.72M
YoY Change	-49.21%
Long-Term Investments
YoY Change
Other Assets	$79.16M	$81.12M
YoY Change
Total Long-Term Assets	$80.61M	$82.43M	$41.69K
YoY Change	-4.61%	197627.23%	26.41%
TOTAL ASSETS
Total Short-Term Assets	$8.037M	$7.095M	$13.26M
Total Long-Term Assets	$80.61M	$82.43M	$41.69K
Total Assets	$88.65M	$89.53M	$13.30M
YoY Change	-3.52%	572.98%	-5.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$935.4K	$922.0K	$797.0K
YoY Change	23.62%	15.69%	222.73%
Accrued Expenses	$2.828M	$1.719M	$16.80K
YoY Change	854.82%	10131.09%	-87.54%
Deferred Revenue
YoY Change
Short-Term Debt	$6.516M	$8.288M	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.74M	$12.57M	$1.037M
YoY Change	803.51%	1112.41%	72.78%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$4.110K	$0.00
YoY Change
Other Long-Term Liabilities		$7.759K
YoY Change
Total Long-Term Liabilities		$11.87K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.74M	$12.57M	$1.037M
Total Long-Term Liabilities		$11.87K	$0.00
Total Liabilities	$11.74M	$12.58M	$1.037M
YoY Change	803.51%	1113.56%	72.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$133.1M	-$128.5M
YoY Change	42.19%
Common Stock	$6.724K	$6.049K
YoY Change	130.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$76.91M	$76.94M	$12.27M
YoY Change
Total Liabilities & Shareholders Equity	$88.65M	$89.53M	$13.30M
YoY Change	-3.52%	572.98%	-5.59%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$4.642M	-$8.506M	-$7.134M
YoY Change	-9.05%	19.24%	110.33%
Depreciation, Depletion And Amortization	$60.32K	$1.544M	$3.040K
YoY Change	-76.27%	50693.75%	50.5%
Cash From Operating Activities	-$5.072M	-$4.716M	-$4.194M
YoY Change	15.87%	12.46%	178.4%
INVESTING ACTIVITIES
Capital Expenditures	$202.6K	$378.8K	-$3.380K
YoY Change	-100.34%	-11305.74%	-16.34%
Acquisitions
YoY Change
Other Investing Activities	-$508.6K	$0.00	-$1.241M
YoY Change	-97.91%	-100.0%
Cash From Investing Activities	-$711.2K	-$378.8K	-$1.244M
YoY Change	-99.15%	-69.55%	30691.09%
FINANCING ACTIVITIES
Cash Dividend Paid		$220.0K
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.216M	$6.551M	212.5K
YoY Change	-92.53%	2983.04%	165.63%
NET CHANGE
Cash From Operating Activities	-5.072M	-$4.716M	-4.194M
Cash From Investing Activities	-711.2K	-$378.8K	-1.244M
Cash From Financing Activities	6.216M	$6.551M	212.5K
Net Change In Cash	431.9K	$1.456M	-5.225M
YoY Change	-109.05%	-127.87%	265.28%
FREE CASH FLOW
Cash From Operating Activities	-$5.072M	-$4.716M	-$4.194M
Capital Expenditures	$202.6K	$378.8K	-$3.380K
Free Cash Flow	-$5.275M	-$5.095M	-$4.190M
YoY Change	-109.61%	21.59%	178.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Assets Assets	89527073	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-40615
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-4533053
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	215 Depot Court SE,
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 215
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Leesburg
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20175
CY2023Q1	dei	City Area Code CityAreaCode	(703)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	436-2121
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $.0001
CY2023Q1	dei	Trading Symbol TradingSymbol	QUBT
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	61512111	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6764866	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5308466	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	63005	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12774	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	224333	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	224302	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	42388	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	42105	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	7094592	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	5587647	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1309100	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	975169	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1212918	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1327746	usd
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	60271	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	60271	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20724419	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22223725	usd
CY2023Q1	us-gaap	Goodwill Goodwill	59125773	usd
CY2022Q4	us-gaap	Goodwill Goodwill	59125773	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	81123381	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	82737515	usd
CY2022Q4	us-gaap	Assets Assets	89300331	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	922032	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	871887	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1718823	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3559981	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1245861	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1357924	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	215119	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	219844	usd
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	8287969	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	535684	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	182046	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	12571850	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6545320	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	4114	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	7632998	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7759	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	225282	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11873	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7858280	usd
CY2023Q1	us-gaap	Liabilities Liabilities	12583723	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14403600	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	149	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	150	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60496062	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	60496062	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55963334	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55963334	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	6049	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5596	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	157348323	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	151163909	usd
CY2023Q1	qubt	Apic Beneficial Conversion Feature In Equity APICBeneficialConversionFeatureInEquity	4898835	usd
CY2022Q4	qubt	Apic Beneficial Conversion Feature In Equity APICBeneficialConversionFeatureInEquity	4898835	usd
CY2023Q1	qubt	Apic Stock Based Compensation APICStockBasedCompensation	43183914	usd
CY2022Q4	qubt	Apic Stock Based Compensation APICStockBasedCompensation	38816022	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-128493920	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-119987781	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	76943350	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	74896731	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	89527073	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	89300331	usd
CY2023Q1	us-gaap	Revenues Revenues	120530	usd
CY2022Q1	us-gaap	Revenues Revenues	31240	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	56239	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	11568	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	64291	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	19672	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1453634	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1116228	usd
CY2023Q1	qubt	Consulting Expenses ConsultingExpenses	225040	usd
CY2022Q1	qubt	Consulting Expenses ConsultingExpenses	370881	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1534597	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1024587	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1968814	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3079803	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2669716	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1137104	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	7851801	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	6728603	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7787510	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6708931	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	31845	usd
CY2022Q1	us-gaap	Interest Income Other InterestIncomeOther	10864	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	214523	usd
CY2023Q1	qubt	Interest Expense Preferred Dividends InterestExpensePreferredDividends	215715	usd
CY2022Q1	qubt	Interest Expense Preferred Dividends InterestExpensePreferredDividends	223125	usd
CY2023Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	320236	usd
CY2022Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	212500	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-718629	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-424761	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8506139	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7133692	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60496062	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29156815	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78817239	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38135094	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16201898	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	212500	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2985453	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7133692	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	12266159	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	74896731	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6551455	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2325000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	596	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1675707	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8506139	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	76943350	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8506139	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7133692	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	44822	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3042	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1499306	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4000707	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2985453	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	123401	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	50231	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	25048	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	30	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-30414	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	49863	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	332135	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1876635	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-470365	usd
CY2023Q1	qubt	Increase Decrease In Preferred Dividends Payable IncreaseDecreaseInPreferredDividendsPayable	-4129	usd
CY2022Q1	qubt	Increase Decrease In Preferred Dividends Payable IncreaseDecreaseInPreferredDividendsPayable	105671	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	2764	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-21443	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4716301	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4193833	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	378754	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3383	usd
CY2022Q1	qubt	Other Current Assets OtherCurrentAssets	-9428	usd
CY2022Q1	qubt	Net Cash Used For Q Photon Merger NetCashUsedForQPhotonMerger	1250000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-378754	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1243955	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	212500	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6551455	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6551455	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	212500	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1456400	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5225288	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5308466	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16738657	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6764866	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11513369	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	250000	usd
CY2022Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	9428	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 1 – <span style="text-decoration:underline">Nature of the Organization and Business </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">Corporate History</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Quantum Computing, Inc. (“Quantum” or the “Company”) was formed in the State of Nevada on July 25, 2001, under its prior name, Ticketcart, Inc. The Company redomiciled to Delaware on February 22, 2018 and changed its name to Quantum Computing Inc. Effective July 20, 2018, the trading symbol for the Company’s common stock, par value $0.0001, on the OTC Market changed from "IBGH” to “QUBT”. On July 15, 2021 the Company uplisted to The NASDAQ Stock Market. On June 16, 2022, the Company merged with QPhoton, Inc., a developer of quantum photonic systems and related technologies and applications.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">Nature of Business</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is a developer of full stack quantum computing systems, including hardware platforms and ready-to-run software for complex optimization computations. The Company was founded in 2018 by leaders in supercomputing, mathematics, and massively parallel programming to solve the enormous challenge with quantum computing in terms of the high cost and lengthy times required for quantum software development. While much of the market focuses on Quantum Processing Unit (QPU) hardware, QCI’s experts realized that the quantum marketplace and vendors were limiting access to quantum computers due to the complexity of programming them. At the present time, only a very limited number of highly specialized quantum experts are able to use software development toolkits (“SDKs”) to create these critical programs and applications. The Company’s software solution, Qatalyst, enables subject matter experts (SMEs) to run existing software on quantum processing units without the need for specialized programming with SDKs. As a result of the merger with QPhoton, Inc. in June 2022, the Company is now able to offer photonic quantum computing systems and related services.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Liquidity</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 28, 2022 the Company filed a shelf registration statement on Form S-3 under the Securities Act of 1933, as amended (the “Securities Act”), which was declared effective on November 8, 2022 (the “2022 shelf”). Under the 2022 Shelf at the time of effectiveness, the Company had the ability to raise up to $100 million by selling common stock, preferred stock, debt securities, warrants and units. On December 5, 2022, the Company entered into an At the Market Issuance Sales Agreement (the “ATM Agreement”) with Ascendiant Capital Markets, LLC (“Ascendiant”) relating to the sale of its common stock, and incorporated the ATM Agreement into the 2022 Shelf by amendment that was declared effective January 10, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms of the ATM Agreement, the Company may, but is not obligated to, offer and sell, from time to time, shares of common stock having an aggregate offering price of up to $25 million through Ascendiant. Sales of common stock, if any, will be made by any method permitted that is deemed an ”at the market offering” as defined in Rule 415 under the Securities Act. The Company intends to use any net proceeds from the sale of securities for our operations and for other general corporate purposes, including, but not limited to, capital expenditures, general working capital, and possible future acquisitions. There were 3,021,632 shares of common stock sold under the ATM Agreement during the three months ended March 31, 2023 and no shares of common stock sold under the ATM Agreement during the three months ended March 31, 2022. As of March 31, 2023, the Company has utilized $6.6 million of the 2022 Shelf. The Company has approximately $93.4 million available under the 2022 Shelf and $18.4 million available under the 2022 Shelf as of March 31, 2023.</p>
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	100000000	usd
CY2023Q1	qubt	Aggregate Offering Price AggregateOfferingPrice	25000000	usd
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3021632	shares
CY2023Q1	qubt	Company Shelf Description CompanyShelfDescription	As of March 31, 2023, the Company has utilized $6.6 million of the 2022 Shelf. The Company has approximately $93.4 million available under the 2022 Shelf and $18.4 million available under the 2022 Shelf as of March 31, 2023.
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	120530	usd
CY2023Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	8506139	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	4716301	usd
CY2023Q1	us-gaap	Other Additional Capital OtherAdditionalCapital	5477258	usd
CY2023Q1	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	128493920	usd
CY2023Q1	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	5780468	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">Use of Estimates:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These financial statements have been prepared in accordance with accounting principles generally accepted in the United States which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates required to be made by management include the determination of reserves for accounts receivable, stockholders equity-based transactions and liquidity assessment. Actual results may differ from these estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	qubt	Intangible Assets Goodwill IntangibleAssetsGoodwill	59125773.38	usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1968814	usd
CY2023Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	5802206	shares
CY2023Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2022Q1	qubt	Promissory Notes PromissoryNotes	1250000	usd
CY2022Q1	us-gaap	Investment Sold Not Yet Purchased Balance Principal Amount InvestmentSoldNotYetPurchasedBalancePrincipalAmount	1250000	usd
CY2022Q2	us-gaap	Investment Sold Not Yet Purchased Balance Principal Amount InvestmentSoldNotYetPurchasedBalancePrincipalAmount	1250000	usd
CY2022Q2	us-gaap	Loans Assumed1 LoansAssumed1	2500000	usd
CY2022Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.06	pure
CY2022Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.15	pure
CY2023Q1	qubt	Extension Year ExtensionYear	P1Y
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4747801	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3248495	usd
CY2023Q1	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	20724419	usd
CY2022Q4	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	22223725	usd
CY2023Q1	qubt	Amortization Of Intangible Assets1 AmortizationOfIntangibleAssets1	1499306	usd
CY2022	qubt	Amortization Of Intangible Assets1 AmortizationOfIntangibleAssets1	3248495	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3726850	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5387847	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2976389	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1372222	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1263889	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	5226156	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22223725	usd
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross	59125773	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	59125773	usd
CY2022Q1	us-gaap	Goodwill Gross GoodwillGross	59125773	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	59125773	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11208100	usd
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5763812	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11208100	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5763812	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	11208100	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1424471	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1045718	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	115371	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	70549	usd
CY2023Q1	us-gaap	Property Plant And Equipment Owned Net PropertyPlantAndEquipmentOwnedNet	1309100	usd
CY2022Q4	us-gaap	Property Plant And Equipment Owned Net PropertyPlantAndEquipmentOwnedNet	975169	usd
CY2023Q1	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	378753	usd
CY2023Q1	qubt	Property Plant And Equipment Collections Capitalized PropertyPlantAndEquipmentCollectionsCapitalized	2500	usd
CY2021Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	200592	usd
CY2021Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	150000	usd
CY2021Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	150000	usd
CY2021Q1	qubt	Total Amount TotalAmount	500592	usd
CY2021Q1	qubt	Total Amount TotalAmount	500592	usd
CY2021Q3	qubt	Total Amount TotalAmount	500592	usd
CY2023Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.06	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2
CY2023Q1	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	375000	usd
CY2023Q1	qubt	Deferred Revenue Lease Current DeferredRevenueLeaseCurrent	125041	usd
CY2022Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	8250000	usd
CY2022Q3	us-gaap	Partners Capital Account Distribution Per Unit Of Limited Partner Interest PartnersCapitalAccountDistributionPerUnitOfLimitedPartnerInterest	10
CY2022Q3	qubt	Original Issue Discount Amount OriginalIssueDiscountAmount	750000	usd
CY2022Q3	qubt	Outstanding Balance OutstandingBalance	1.20	pure
CY2023Q1	qubt	Redemption Amount RedemptionAmount	750000	usd
CY2023Q1	us-gaap	Certain Loans Acquired In Transfer Accounted For As Available For Sale Debt Securities Outstanding Balance CertainLoansAcquiredInTransferAccountedForAsAvailableForSaleDebtSecuritiesOutstandingBalance	1000000	usd
CY2023Q1	qubt	Interest Rate Of Lesser InterestRateOfLesser	0.15	pure
CY2021Q4	qubt	Convertible Preferred Stock Par Value ConvertiblePreferredStockParValue	0.0001
CY2023Q1	us-gaap	Percentage Of Debt Hedged By Interest Rate Derivatives PercentageOfDebtHedgedByInterestRateDerivatives	0.10	pure
CY2023Q1	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	5.5
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	7
CY2022Q2	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	one of the investors in the Series A Convertible Preferred financing round, Falcon Capital Partners, converted 45,455 shares of Series A Convertible Preferred stock into 47,728 shares of the Company’s Common Stock.
CY2022Q4	qubt	Merger Agreement Description MergerAgreementDescription	the Company issued 155,000 shares of common stock to seven employees and consultants in exchange for services rendered.
CY2023Q1	qubt	Shares Available For Issue SharesAvailableForIssue	3000000	shares
CY2022Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	16000000	shares
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1240633	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15003002	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	9601237	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.42
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	592500	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.84
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	10193737	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.33
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y9M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6899569	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.35
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M18D
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	10193737	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6899569	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.81
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.38
CY2023Q1	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	728181	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	2758465	usd
CY2022	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	125238	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	17761467	usd
CY2023Q1	qubt	Common Stock Options CommonStockOptions	6800000	usd
CY2023Q1	qubt	Expected To Be Recognized Over A Period ExpectedToBeRecognizedOverAPeriod	P2Y9M18D
CY2020Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	171000	shares
CY2020Q3	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	2
CY2021Q4	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1545459	shares
CY2021Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	7
CY2022Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	6325503	shares
CY2022Q2	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.0001
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	263480	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	343652	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	341081	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	349608	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	267092	usd
CY2023Q1	qubt	Imputed Interest ImputedInterest	347074	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1217839	usd
CY2023Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	93719	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y4M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y8M12D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q1	qubt	Consideration Agreement Description ConsiderationAgreementDescription	As consideration for the license and other rights granted under the agreement, QPhoton agreed to pay the following: (i) $35,000 within 30 days of execution of the agreement, (ii) $28,000 within 30 days of each annual anniversary of the effective date, (iii) equity in the Company equivalent to nine percent of the membership units of the Company within 30 days of the execution of the agreement, and (iv) royalties of 3.5% of the Net Sales Price of each licensed product sold or licensed by the company during the quarter then-ended, for which it also received payment, concurrent with the delivery of the relevant quarterly report.
CY2023Q1	qubt	Royalties Fee Percentage RoyaltiesFeePercentage	0.035	pure
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Quantum Computing Inc.
CY2023Q1	qubt	Misc Income Government Grants MiscIncomeGovernmentGrants		usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2023Q1	qubt	Interest Expense Warrants InterestExpenseWarrants		usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2022Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss		usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss		usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	53568.44	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001758009

Files In Submission

Name	View Source	Status
0001213900-23-038633-index-headers.html	Edgar Link	pending
0001213900-23-038633-index.html	Edgar Link	pending
0001213900-23-038633.txt	Edgar Link	pending
0001213900-23-038633-xbrl.zip	Edgar Link	pending
f10q0323ex31-1_quantumcomp.htm	Edgar Link	pending
f10q0323ex31-2_quantumcomp.htm	Edgar Link	pending
f10q0323ex32-1_quantumcomp.htm	Edgar Link	pending
f10q0323ex32-2_quantumcomp.htm	Edgar Link	pending
f10q0323_quantumcomp.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qubt-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
qubt-20230331_cal.xml	Edgar Link	unprocessable
qubt-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
qubt-20230331_lab.xml	Edgar Link	unprocessable
qubt-20230331_pre.xml	Edgar Link	unprocessable
f10q0323_quantumcomp_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QUBT
Quantum Computing Inc. Stock $qubt

2023 Q2 Form 10-Q Financial Statement

#000121390023038633 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QUBT Quantum Computing Inc. Stock $qubt

2023 Q2 Form 10-Q Financial Statement

#000121390023038633 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QUBT
Quantum Computing Inc. Stock $qubt